Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.

UNLABELLED Infusion of glucagon causes only a transient increase in glucose production in normal and diabetic man. To assess the effect of intermittent endogenous hyperglucagonemia that might more closely reflect physiologic conditions, arginine (10 g over 30 min) was infused four times to 8 normal subjects and 13 insulin-dependent diabetic subjects (4 of whom were infused concomitantly with somatostatin to examine effects of arginine during prevention of hyperglucagonemia). Each arginine infusion was separated by 60 min. Diabetic subjects were infused throughout the experiments with insulin at rates (0.07-0.48 mU/kg per min) that had normalized base-line plasma glucose and rates of glucose appearance (Ra) and disappearance (Rd). Basal plasma glucagon and arginine-induced hyperglucagonemia were similar in both groups; basal serum insulin in the diabetics (16+/-1 muU/ml, P < 0.05) exceeded those of the normal subjects (10+/-1 muU/ml, P < 0.05) but did not increase with arginine. Serum insulin in normal subjects increased 15-20 muU/ml with each arginine infusion. In both groups each arginine infusion increased plasma glucose and Ra. Increments of Ra in the diabetics exceeded those of normal subjects, (P < 0.02); Rd was similar in both groups. In normal subjects, plasma glucose returned to basal levels after each arginine infusion, whereas in the diabetics hyperglycemia persisted reaching 151+/-15 mg/dl after the last arginine infusion. When glucagon responses were prevented by somatostatin, arginine infusions did not alter plasma glucose or Ra. CONCLUSIONS Infusion of arginine acutely increases plasma glucose and glucose production in man solely by stimulating glucagon secretion; physiologic increments in plasma glucagon (100-150 pg/ml) can result in sustained hyperglycemia when pancreatic beta cell function is limited.

[1]  A. Cherrington,et al.  Effect of glucagon on glucose production during insulin deficiency in the dog. , 1978, The Journal of clinical investigation.

[2]  P. Raskin,et al.  Hyperglucagonemia and its suppression. Importance in the metabolic control of diabetes. , 1978, The New England journal of medicine.

[3]  S. Bhathena,et al.  Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia. , 1978, The Journal of clinical investigation.

[4]  P. Felig,et al.  Regulation of the glucagon receptor by physiological hyperglucagonaemia , 1978, Nature.

[5]  P. Raskin,et al.  Effect of Insulin Therapy on the Profiles of Plasma Immunoreactive Glucagon in Juvenile-type and Adult-type Diabetics , 1978, Diabetes.

[6]  P. Felig,et al.  Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats. , 1978, The Journal of clinical investigation.

[7]  R. Unger,et al.  Binding and biologic activity of glucagon in liver cell membranes of chronically hyperglucagonemic rats. , 1977, The Journal of biological chemistry.

[8]  R. DeFronzo,et al.  Influence of glucagon replacement on the hyperglycemic and hyperketonemic response to prolonged somatostatin infusion in normal man. , 1977, The Journal of clinical endocrinology and metabolism.

[9]  S. B. Lewis,et al.  Transient Stimulatory Effect of Sustained Hyperglucagonemia on Splanchnic Glucose Production in Normal and Diabetic Man , 1977, Diabetes.

[10]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[11]  L. Orci,et al.  Physiology and pathophysiology of glucagon. , 1976, Physiological reviews.

[12]  P. Felig,et al.  Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man. , 1976, The Journal of clinical investigation.

[13]  P. Felig,et al.  Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. , 1976, The Journal of clinical investigation.

[14]  R. Sherwin,et al.  Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. , 1976, The New England journal of medicine.

[15]  F. DeRubertis,et al.  Reduced sensitivity of the hepatic adenylate cyclase-cyclic AMP system to glucagon during sustained hormonal stimulation. , 1976, The Journal of clinical investigation.

[16]  R. Steele,et al.  Glucose turnover values in the dog obtained with various species of labeled glucose. , 1975, The American journal of physiology.

[17]  C. Plas,et al.  Glycogenolytic response to glucagon of cultured fetal hepatocytes. Refractoriness following prior exposure to glucagon. , 1975, The Journal of biological chemistry.

[18]  P. Felig,et al.  Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus. , 1975, The Journal of clinical investigation.

[19]  E. Tsalikian,et al.  Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. , 1975, The New England journal of medicine.

[20]  N. Christensen,et al.  Glucagon and plasma catecholamine responses to graded and prolonged exercise in man. , 1975, Journal of applied physiology.

[21]  K. Tranberg,et al.  Pancreatic glucagon response to an ordinary meal. , 1975, Scandinavian journal of gastroenterology.

[22]  M. Vranic,et al.  Arginine Infusion in Dogs: Model for the Roles of Insulin and Glucagon in Regulating Glucose Turnover and Free Fatty Acid Levels , 1974, Diabetes.

[23]  M. Vranic,et al.  Effect of interaction between insulin and glucagon on glucose turnover and FFA concentration in normal and depancreatized dogs. , 1974, Metabolism: clinical and experimental.

[24]  K. Norwich,et al.  Measurement and validation of nonsteady turnover rates with applications to the inulin and glucose systems. , 1974, Federation proceedings.

[25]  K. Mashimo,et al.  A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients , 1973, Diabetes.

[26]  P. Felig,et al.  The Glycemic Response to Arginine in Man , 1972, Diabetes.

[27]  G. Hetényi,et al.  Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method. , 1971, Metabolism: clinical and experimental.

[28]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[29]  R. Steele,et al.  Effect of insulin on utilization and production of circulating glucose. , 1957, The American journal of physiology.